Eli Lilly’s next-generation obesity drug helped patients lose up to 34 pounds in clinical trial By: MarketWatch April 27, 2023 at 14:06 PM EDT New drug is among next-generation weight-loss medications generating debate over insurance coverage, costs Read More >> Related Stocks: Eli Lilly Novo Nordisk A/S ADR